magAssist Ranked Among the Future Healthcare 100 for the Fifth Consecutive Year

Recently, the results of the 10th Future Healthcare 100 Awards (2026 Edition), organized by VB100 of Artery Network, were officially announced. Leveraging its accumulated technological innovation, stable clinical implementation of its products, and well-established intelligent manufacturing capabilities, magAssist was successfully selected for the 2026 Future Healthcare 100 – Innovative Medical Devices & Intelligent Manufacturing Top 100 List.

To date, magAssist has been recognized on the Future Healthcare 100 list for five consecutive years.

The company has remained deeply committed to the innovative medical device sector, consistently pursuing independent technological innovation while advancing intelligent manufacturing upgrades. By strengthening both R&D and smart manufacturing capabilities, magAssist continues to contribute to the development of China's life-support industry.

——2026 Future Healthcare 100——

Innovative Medical Devices & Intelligent Manufacturing Top 100

At present, technological innovation and intelligent manufacturing have become major drivers of development in the medical device industry. Based on industry trends and practical clinical needs, magAssist has consistently adhered to a pragmatic innovation approach. On one hand, the company continues to tackle core technologies and address key technical gaps within the industry. On the other hand, it steadily advances intelligent production line transformation, enabling the large-scale and standardized manufacturing of critical medical equipment while balancing innovation capabilities with practical production capacity.

Leveraging independently developed technologies, the company has established three comprehensive product pipelines, including a fully magnetically levitated extracorporeal ventricular assist device (MoyoAssist®), ECMO (BreathMo®), and a percutaneous ventricular assist device (NyokAssist®). In parallel, magAssist has built intelligent manufacturing facilities capable of supporting large-scale production of these products.

While continuously iterating products and optimizing technical solutions, the company has also enhanced intelligent manufacturing processes, improving production efficiency and quality control standards. Through standardized and scalable smart manufacturing, magAssist ensures a stable supply and reliable quality of emergency life-support devices, enabling innovative technologies to reach clinical practice and benefit patients.

Looking Ahead

Moving forward, magAssist will remain committed to its founding mission and continue focusing on the development of life-support technologies. Guided by technological innovation and supported by intelligent manufacturing, the company will continue to optimize product performance, accelerate the translation of clinical achievements, and dedicate itself to delivering every life-support device with the highest standards of quality and reliability.

Through continuous innovation and intelligent manufacturing, magAssist will continue supporting the treatment of critically ill patients and contribute to the steady and healthy development of China's medical device industry.